These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7473478)

  • 21. Efficacy of hydroxychloroquine in hand osteoarthritis: A protocol for systematic review and meta-analysis of randomized clinical trial.
    Li QQ; Xie YD; Liang WQ; Yang GQ; Zhang HB; Wang YP
    Medicine (Baltimore); 2020 Dec; 99(50):e23517. PubMed ID: 33327296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of disease-modifying anti-rheumatic drugs in osteoarthritis: A meta-analysis.
    Mathieu S; Tournadre A; Soubrier M; Sellam J
    Joint Bone Spine; 2022 Nov; 89(6):105444. PubMed ID: 35908643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble interleukin 2 receptors and treatment with hydroxychloroquine in erosive osteoarthritis.
    Punzi L; Bertazzolo N; Pianon M; Michelotto M; Todesco S
    J Rheumatol; 1996 Aug; 23(8):1477-8. PubMed ID: 8856633
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rheumatoid polyarthritis, regressive course of erosive lesions. Apropos of a case treated with hydroxychloroquine].
    Job-Deslandre C; Menkès CJ
    Rev Rhum Ed Fr; 1993 Oct; 60(9):630-1. PubMed ID: 8012344
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
    Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
    JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.
    Yogasundaram H; Putko BN; Tien J; Paterson DI; Cujec B; Ringrose J; Oudit GY
    Can J Cardiol; 2014 Dec; 30(12):1706-15. PubMed ID: 25475472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.
    van Riel PL; van der Heijde DM; Nuver-Zwart IH; van de Putte LB
    J Rheumatol; 1995 Sep; 22(9):1797-9. PubMed ID: 8523366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
    Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis.
    Wittoek R; Cruyssen BV; Verbruggen G
    Arthritis Rheum; 2012 May; 64(5):1430-6. PubMed ID: 22139828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roentgenologic, immunologic, and therapeutic study of erosive (inflammatory) osteoarthritis.
    Utsinger PD; Resnick D; Shapiro RF; Wiesner KB
    Arch Intern Med; 1978 May; 138(5):693-7. PubMed ID: 646532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI).
    Yokogawa N; Kato Y; Sugii S; Inada S
    Mod Rheumatol; 2012 Apr; 22(2):249-55. PubMed ID: 21842436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
    Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
    Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis: how physicians manage treatment failures.
    Spencer-Green G; Spencer-Green E
    J Rheumatol; 1998 Nov; 25(11):2088-93. PubMed ID: 9818649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.
    Wasko MC; Hubert HB; Lingala VB; Elliott JR; Luggen ME; Fries JF; Ward MM
    JAMA; 2007 Jul; 298(2):187-93. PubMed ID: 17622600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
    Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
    JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
    Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.